Company & Sponsor Intelligence
University College, London
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials2
Recruiting0
Completed1
Countries1
Therapeutic footprint
parkinsonsunclassified
Indexed studies
NCT03421899A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular "Powerhouse") Dysfunction
parkinsons · United KingdomCOMPLETED
parkinsons · United KingdomCOMPLETED
NCT02490046D-mannose for the Prevention of UTIs in Multiple Sclerosis
unclassified · United KingdomPHASE1
unclassified · United KingdomPHASE1
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →